Is CytomX Therapeutics Inc (NASDAQ: CTMX) Back In The Buying Zone?
Currently, there are 80.10M common shares owned by the public and among those 78.05M shares have been available to trade. The company’s stock has a 5-day price change of -1.82% and -45.94% over the past three months. CTMX shares are trading -35.45% year to date (YTD), with the 12-month market performance down to -75.56% lower. […]
